Phytoconstituent-derived nano-medicines/vesicles providing a promising dawn for inflammatory bowel disease
Authors:
- Linzhou YinLYLinzhou Yin
- Xiaowen JiangXJXiaowen Jiang
- Miao WangMWMiao Wang
- Yiren YangYYYiren Yang
- Zhonggui HeZHZhonggui He
- Jin SunJSJin Sun
- Huiyuan GaoHGHuiyuan Gao
- Mengchi SunMSMengchi Sun
- 8 July 2024
- journal article
- review article
- Published by Elsevier in Chinese Chemical Letters
- Vol. 36 (6)
Abstract
No abstract availableFunding Information
- Liaoning Revitalization Talents Program (XLYC 1905019)
- National Natural Science Foundation of China (82273824, 31670359, 82372111)
This publication has 187 references indexed in Scilit:
- Stimuli‐responsive crosslinked nanomedicine for cancer treatmentExploration, 2022
- Advances in Food Chemistry2022
- Distinctive Cassane Diterpenoids Corroborated Biogenetic Evolutionary Process from Caesalpinia mimosoides with Anti‐renal Fibrosis ActivityChinese Journal of Chemistry, 2021
- Recent strategies in nanodelivery systems for natural products: a reviewEnvironmental Chemistry Letters, 2021
- Emerging carrier‐free nanosystems based on molecular self‐assembly of pure drugs for cancer therapyMedicinal Research Reviews, 2020
- Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cellsJournal of Leukocyte Biology, 2019
- The CD44‐Mediated Uptake of Hyaluronic Acid‐Based Carriers in MacrophagesAdvanced Healthcare Materials, 2016
- Phytochemicals and Their Potential Usefulness in Inflammatory Bowel DiseasePhytotherapy Research, 2015
- Understanding the Mechanical Properties of Antheraea Pernyi Silk—From Primary Structure to Condensed Structure of the ProteinAdvanced Functional Materials, 2011
- Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitisEuropean Journal of Nutrition, 2009